INMUNE BIO INC. (INMB) Net margin 2020–2025
INMUNE BIO INC. (INMB) net profit margin by fiscal year — reported net income divided by reported revenue.
-91866.0%FY2025 · since FY2020: -109990.9% → -91866.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -91866.0% | +208719.7 pp |
| FY2024 | -300585.7% | -281225.7 pp |
| FY2023 | -19360.0% | -12060.8 pp |
| FY2022 | -7299.2% | +9463.2 pp |
| FY2021 | -16762.4% | +93228.5 pp |
| FY2020 | -109990.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INMB financial trends
INMB RevenueINMB Net incomeINMB Gross profitINMB Gross marginINMB Operating incomeINMB Operating marginINMB Operating cash flowINMB Free cash flowINMB Capital expendituresINMB Return on equityINMB Stock buybacksINMB Dividends paidINMB Total assetsINMB Total liabilitiesINMB Shareholders’ equityINMB overview →